COMMUNIQUÉS West-GlobeNewswire

Lexicon Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on May 1, 2019
25/04/2019
THE WOODLANDS, Texas, April 25, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its first quarter 2019 financial results on Wednesday, May 1, 2019 before market opens. Management will [...]
Stemline Therapeutics Announces New England Journal of Medicine Publication of ELZONRIS (tagraxofusp) Pivotal Study Results
25/04/2019
NEW YORK, April 25, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline
25/04/2019
-Merger creates a publicly-traded clinical stage immuno-oncology company developing treatments for advanced cancers including aggressive brain tumors, pancreatic cancer, and melanoma -Phase 2 clinical data on lead [...]
MyDx Announces 2018 Fiscal Year Results and Shareholder Update
25/04/2019
SAN DIEGO, CA, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – MyDx, Inc. ( OTC: MYDX ), a leader in science based cannabis health technologies, announced that it has filed its 2018 10-K annual report and is [...]
Decision by the Board of Directors to acquire own shares
25/04/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 25 APRIL 2019 at 12.30 EEST Decision by the Board of Directors to acquire own shares The Board of Directors of Orion Corporation decided on 25 April 2019 on a share acquisition [...]
Orion Group Interim Report January-March 2019
25/04/2019
ORION CORPORATION INTERIM REPORT JANUARY-MARCH 2019 25 APRIL 2019 at 12.00 EEST Orion Group Interim Report January-March 2019 Net sales in January-March 2019 totalled EUR 241 million (EUR 247 million in January-March [...]
Philips launches IntelliSpace Radiation Oncology to accelerate time from patient referral to the start of treatment
25/04/2019
April 25, 2019 Intelligent patient management solutions on display at ESTRO 2019 to complement latest radiotherapy imaging and treatment planning innovations Amsterdam, the Netherlands and Milan, Italy – Royal Philips ( [...]
LIDDS invited to speak at Formulation and Drug Delivery Congress in London
25/04/2019
Director of Pharmaceutical R&D, Stefan Grudén, has been invited to present at the Annual Formulation and Drug Delivery Congress being held in London on 29-30 April. This annual congress is an important event for [...]
Financière de Tubize SA : Approbation du dividende
25/04/2019
Communiqué de presse FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: aspijcke, directeur, aspijcke@icloud.com Approbation du dividende Information réglementée 24 avril 2019 L'assemblée générale [...]
Biocartis Group NV: BIOCARTIS Q1 2019 BUSINESS UPDATE
25/04/2019
PRESS RELEASE : REGULATED INFORMATION Thursday 25 April 2019, 07:00 CEST BIOCARTIS Q1 2019 BUSINESS UPDATE Mechelen, Belgium , 25 April 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
ACACIA PHARMA ANNOUNCES POSITIVE PHASE 3 BARHEMSYS® RESCUE TREATMENT DATA TO BE PRESENTED AT THE ANNUAL CONGRESS OF ENHANCED RECOVERY AND PERIOPERATIVE MEDICINE
25/04/2019
Cambridge, UK and Indianapolis, US – 25 April 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) announces that additional data and analyses from its positive Phase 3 clinical trial of [...]
Bone Therapeutics announces publication of Annual Report 2018 and Extraordinary General Meeting on 23 May 2019
25/04/2019
Regulated information Gosselies, Belgium, 25 April 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics annonce la publication de son Rapport Annuel 2018 et la tenue d’une Assemblée Générale Extraordinaire le 23 mai 2019
25/04/2019
Information réglementée Gosselies, Belgique, le 25 avril 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE, éligible PEA-PME), société de thérapie cellulaire osseuse qui répond à d’importants [...]
Active Biotech AB - Interim report January - March 2019
25/04/2019
First quarter in brief Active Biotech's partner NeoTX entered clinical collaboration with AstraZeneca to evaluate ANYARA ("naptumumab") in combination with IMFINZI® (durvalumab) in the upcoming Phase Ib/II study On 1 [...]
Constitutive meeting of Biohit Oyj’s Board of Directors
25/04/2019
Biohit Oyj: Other information disclosed according to the rules of the Exchange April 25, 2019 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the [...]
Q1 conference call
25/04/2019
Vistin Pharma ASA Quarterly Report – Q1 2019 25 April 2019, 08:30 CET Telephone conference: Confirmation Code:.............. 7481935 International Dial-In: ............ +44 (0) 2071 928000 Norway, Oslo: 23960264 United [...]
Acarix publishes the annual report for 2018
25/04/2019
Press release Malmö, April 25, 2019 Acarix publishes the annual report for 2018 Today, Thursday April 25, Acarix is publishing its Annual Report for 2018 on the company website www.acarix.com . The Annual Report is also [...]
Immunicum AB (publ) Interim Report January - March 2019
25/04/2019
Press Release 25 April 2019 Immunicum AB (publ) Interim Report January - March 2019 Preparations for Upcoming Clinical Data in the MERECA and GIST Studies and First Patient Treated in the ILIAD Study Significant Events [...]
Financière de Tubize SA : Approval of dividend
25/04/2019
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, general manager, aspijcke@icloud.com Approval of dividend Regulated information 24 April 2019 The general [...]

Pages